Grillo Anthony S, SantaMaria Anna M, Kafina Martin D, Cioffi Alexander G, Huston Nicholas C, Han Murui, Seo Young Ah, Yien Yvette Y, Nardone Christopher, Menon Archita V, Fan James, Svoboda Dillon C, Anderson Jacob B, Hong John D, Nicolau Bruno G, Subedi Kiran, Gewirth Andrew A, Wessling-Resnick Marianne, Kim Jonghan, Paw Barry H, Burke Martin D
Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Science. 2017 May 12;356(6338):608-616. doi: 10.1126/science.aah3862.
Multiple human diseases ensue from a hereditary or acquired deficiency of iron-transporting protein function that diminishes transmembrane iron flux in distinct sites and directions. Because other iron-transport proteins remain active, labile iron gradients build up across the corresponding protein-deficient membranes. Here we report that a small-molecule natural product, hinokitiol, can harness such gradients to restore iron transport into, within, and/or out of cells. The same compound promotes gut iron absorption in DMT1-deficient rats and ferroportin-deficient mice, as well as hemoglobinization in DMT1- and mitoferrin-deficient zebrafish. These findings illuminate a general mechanistic framework for small molecule-mediated site- and direction-selective restoration of iron transport. They also suggest that small molecules that partially mimic the function of missing protein transporters of iron, and possibly other ions, may have potential in treating human diseases.
多种人类疾病源于铁转运蛋白功能的遗传性或后天性缺陷,这种缺陷会减少不同位点和方向的跨膜铁通量。由于其他铁转运蛋白仍保持活性,不稳定的铁梯度会在相应的蛋白质缺陷膜上积累。在此,我们报告一种小分子天然产物,扁柏酚,可利用这种梯度来恢复铁进出细胞以及在细胞内的转运。该化合物同样能促进二价金属离子转运体1(DMT1)缺陷大鼠和铁转运蛋白缺陷小鼠的肠道铁吸收,以及DMT1和线粒体铁转运蛋白缺陷斑马鱼的血红蛋白化。这些发现阐明了小分子介导的铁转运位点和方向选择性恢复的一般机制框架。它们还表明,部分模拟缺失的铁及可能其他离子的蛋白质转运体功能的小分子,可能在治疗人类疾病方面具有潜力。